Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 25 min ago
Peer-reviewedCC BYPharmaceutics

Barrier-Guided Local Nanopharmaceutics for Cartilage and Osteochondral Regeneration: From Effective Tissue Exposure to Cell-State Control and Translational Quality Attributes

Related

  1. Articular calcified cartilage microarchitecture has a predictive role in abnormal osteochondral strain distributions in murine age-related osteoarthritis
    L. A. Evans, A. Sharma, J. Chen +8
    bioRxivPreprintCC BY-NC-NDFull textPhysiologybioRxiv
  2. Multifunctional hydrogel scaffolds for endogenous osteochondral regeneration
    Ling Zhang, Xuan Liu, Jinping Liang +8
    Regenerative therapyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. PTHrP suppresses BMP2-induced osteochondral differentiation and preserves cartilage phenotype in mesenchymal stem cells via inactivating PI3K-AKT signaling.
    Shengqiang Gao, Piao Zhao, Tingting Du +9
    Genes & diseasesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Nose-to-Knee Transplantation for Osteochondral Regeneration: A Proof-of-Concept Study in Sheep Employing Ceramic-Hydrogel Osteochondral Grafts
    P. Fisch, I. Roohani, S. Ponta +9
    bioRxivPreprintCC BYFull textSystems & synthetic biologybioRxiv
  5. Osteochondral Cell Fate in the Mandibular Condyle: A Shared Fate Decision Across Development, Degeneration, and Regeneration
    Lingfeng Xu, Meiqing Wang
    CellsPeer-reviewedCC BY 4.0Full textCell biologyCrossrefEurope PMC
BibTeX
@article{anon2026barrierguided,
  title = {{Barrier-Guided Local Nanopharmaceutics for Cartilage and Osteochondral Regeneration: From Effective Tissue Exposure to Cell-State Control and Translational Quality Attributes}},
  journal = {Pharmaceutics},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13708104},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Barrier-Guided Local Nanopharmaceutics for Cartilage and Osteochondral Regeneration: From Effective Tissue Exposure to Cell-State Control and Translational Quality Attributes
PY  - 2026
DA  - 2026/09/23
JO  - Pharmaceutics
UR  - https://europepmc.org/article/PMC/PMC13708104
SN  - 1999-4923
ER  -